Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | CTSG | P08311 | 1/20 | 0.39 |
| ▸ | CTRC | Q99895 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3152073 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1MAPTMGLL | |
| SCHEMBL1426485 | 0.77 | LMNA (0.41) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL9908789 | 0.76 | MAPT (0.49) | LMNAALDH1A1MAPTNPSR1 | |
| SCHEMBL13710838 | 0.76 | — | — | |
| SCHEMBL17722421 | 0.74 | — | — | |
| SCHEMBL5252516 | 0.72 | MEN1 (0.53) | F2ELANECTSGCTRCALDH1A1 | |
| SCHEMBL1427035 | 0.71 | LMNA (0.37) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL11046045 | 0.70 | MAPT (0.33) | LMNAALDH1A1MAPTMGLL | |
| SCHEMBL1263088 | 0.70 | MEN1 (0.37) | BLM | |
| SCHEMBL8566934 | 0.69 | LMNA (0.32) | F2ELANECTSGCTRCLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250213434-A1 | DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY | KURARAY NORITAKE DENTAL INC. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250207005-A1 | ADHESIVE COMPOSITION FOR STEREOLITHOGRAPHIC ARTICLE AND NON-STEREOLITHOGRAPHIC ARTICLE | KURARAY NORITAKE DENTAL INC. (JP) | 2025-06-26 | — | — | US | disclosed |
| WO-2025126917-A1 | DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2025-06-19 | — | — | WO | disclosed |
| EP-3542775-B1 | COMPOSITION WITH EXCELLENT STORAGE STABILITY USING HIGHLY BASIC FILLER | SHOFU INC (JP) | 2025-04-02 | — | — | EP | disclosed |
| US-20250064686-A1 | DENTAL CURABLE COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | SHOFU INC (JP) | 2025-02-27 | — | — | US | disclosed |
| US-20250057732-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2025-02-20 | — | — | US | disclosed |
| US-20250057733-A1 | CURABLE DENTAL COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2025-02-20 | — | — | US | disclosed |
| EP-2112177-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | Kuraray Medical Inc. (JP) | 2009-10-28 | — | — | EP | disclosed |
| EP-2112178-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | Kuraray Medical Inc. (JP) | 2009-10-28 | — | — | EP | disclosed |
| EP-2108664-A1 | COMPOSITION AND DENTAL MATERIAL | Kuraray Medical Inc. (JP) | 2009-10-14 | — | — | EP | disclosed |
| EP-2108663-A1 | POLYMERIZABLE MONOMER, POLYMERIZABLE COMPOSITION AND DENTAL MATERIAL | Kuraray Medical Inc. (JP) | 2009-10-14 | — | — | EP | disclosed |
| CN-101547930-A | Novel compound, composition containing same, and method for producing polymerizable amide | KURARAY MEDICAL INC (JP) | 2009-09-30 | — | — | CN | disclosed |
| US-20090163505-A1 | AMINO-HETEROARYL-CONTAINING PROKINETICIN 1 RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-25 | — | — | US | disclosed |
| EP-2070935-A1 | NOVEL COMPOUND, COMPOSITION COMPRISING THE SAME, AND PROCESS FOR PRODUCTION OF POLYMERIZABLE AMIDE | Kuraray Medical Inc. (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-20080287445-A1 | Prokineticin 2 receptor antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-11-20 | — | — | US | disclosed |
| US-20080269225-A1 | Prokineticin 1 receptor antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-10-30 | — | — | US | disclosed |
| US-20080045535-A1 | Prokineticin 2 receptor antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045535-A1 | Prokineticin 2 receptor antagonists | PROKR2, PROKR1, GIPR | F2 1122/4885ELANE 2493/4885CTSG 699/4885 |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | F2 4177/4885ELANE 2217/4885CTSG 944/4885 |
| US-12465559-B2 | Fluorescent curable dental composition and cured product thereof | BRD1, TBCA, BAZ1A | F2 3748/4885ELANE 2993/4885CTSG 1067/4885 |
| US-20250064686-A1 | DENTAL CURABLE COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | ERCC1, DSC1, CRYAA | F2 644/4885ELANE 3775/4885CTSG 1871/4885 |
| US-20080269225-A1 | Prokineticin 1 receptor antagonists | PROKR1, PROKR2, GIPR | F2 1725/4885ELANE 1852/4885CTSG 699/4885 |
| US-20250207005-A1 | ADHESIVE COMPOSITION FOR STEREOLITHOGRAPHIC ARTICLE AND NON-STEREOLITHOGRAPHIC ARTICLE | ACR, CAD, ALG3 | F2 773/4885ELANE 2007/4885CTSG 3995/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | F2 3548/4885ELANE 647/4885CTSG 4609/4885 |
| US-20250057732-A1 | DENTAL CURABLE COMPOSITION | CAD, MMAB, DNMT3L | F2 4799/4885ELANE 4259/4885CTSG 3421/4885 |
| US-20090163505-A1 | AMINO-HETEROARYL-CONTAINING PROKINETICIN 1 RECEPTOR ANTAGONISTS | PROKR1, PROKR2, GIPR | F2 2986/4885ELANE 3350/4885CTSG 1181/4885 |
| US-20080287445-A1 | Prokineticin 2 receptor antagonists | PROKR2, PROKR1, GIPR | F2 1552/4885ELANE 2606/4885CTSG 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.